Sign in
4

Changes in Ownership

Keros Therapeutics, Inc. Filed Acc 0001797917-26-000009

Director sold 574 shares at $9.79 ($5,619)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Prener Anne Director 2026-11-12 Sale 10b5-1 −574 $9.79 $5,619 13,212 D: show line 1 in the form
Open-market sales · 574 sh · avg $9.79 · $5,619
Loading xslF345X06/form4-11162026_041102.xml…